Advertisement
Home 2025

Archives

Environmental Benefit Seen With GLP-1 Receptor Agonist Use in Heart Failure

0

Heart failure event-related greenhouse gas emissions estimated at 9.45 and 9.70 kg CO2e per patient per year for GLP-1 RA and placebo users, respectively

Older Age, Lower Fitness Linked to Atrial Ectopic Burden

0

Older age was also an independent risk factor for ventricular ectopic burden; lower eGFR linked to high AEB, VEB

Diabetes Risk Commonly Clustered Within Households

0

Health systems can use electronic health record data to target households rather than just individuals, authors say

Opportunistic Community Screening IDs Uncontrolled Cardiovascular Risk Factors

0

Overall, 68.9 percent of participants who underwent screening at health stations had uncontrolled cardiovascular risk factors

Three Healthy Dietary Patterns Lower Incidence of Type 2 Diabetes Across Ethnicities

0

No significant heterogeneity seen across ethnic groups, nor evidence of small-study bias

Lifestyle Interventions Improve Cognition for At-Risk Older Adults

0

Significantly greater benefit on global cognition seen for structured versus self-guided intervention over two years

ENDO: Guidelines Developed for Pregnancy Care in Preexisting Diabetes

0

Discontinuation of GLP-1 receptor agonists suggested before conception rather than between start of pregnancy and end of first trimester

ENDO: AI Model Integrated Into Retina Tracker IDs Diabetic Retinopathy

0

The EfficientNetB0 achieved more than 99 percent accuracy, with image processing speed <1 second per image

ENDO: Primary Aldosteronism Screening Recommended for All With Hypertension

0

Screening should include measuring aldosterone and renin and determining the aldosterone-to-renin ratio

ENDO: Osteoporosis Treatment Benefits Elderly Patients With Fragility Fracture

0

Benefits include lower incidence of all-cause mortality, hospitalizations